title: Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
abstract: PTH clearly plays a role in maintaining the hypercalcemia of familial benign hypercalcemia (FBH or familial hypocalciuric hypocalcemia). To better define the abnormalities of parathyroid function in FBH and primary hyperparathyroidism (1 degree HPT), we used a two-site immunochemiluminometric assay for intact PTH to examine PTH suppressibility in normal individuals and patients having FBH or 1 degree HPT. Twelve normal, 11 FBH, and 7 1 degree HPT subjects were given calcium (Ca) iv with frequent sampling for ionized Ca and intact PTH. In normal and FBH subjects, plasma PTH levels decreased essentially identically in response to iv Ca. In the 1 degree HPT group, PTH was not normally suppressible. However, there was a spectrum of responsiveness in 1 degree HPT patients, with a significant correlation between tumor mass and degree of PTH nonsuppressibility (r = 0.87, P = 0.01). Analysis of the relationship between plasma PTH and ionized Ca values in the three groups demonstrated a shift to the right in the FBH curve, with no difference of slope, consistent with the notion of a simple "set-point" error in FBH. In contrast, the curve in 1 degree HPT was not only shifted to the right but also differed from normal in slope (normal, -8.92; 1 degree HPT, -3.92, P = 0.04). Thus, we propose that the parathyroid functional abnormality in FBH represents a simple set-point error, whereas the defect in 1 degree HPT consists of a set-point error combined with varying degrees of Ca nonsuppressible PTH secretion that may be related to tumor mass.
authors.affiliation: Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
authors.forename: S
authors.initials: S
authors.lastname: Khosla
authors.forename: P R
authors.initials: PR
authors.lastname: Ebeling
authors.forename: A F
authors.initials: AF
authors.lastname: Firek
authors.forename: M M
authors.initials: MM
authors.lastname: Burritt
authors.forename: P C
authors.initials: PC
authors.lastname: Kao
authors.forename: H
authors.initials: H
authors.lastname: Heath
mesh_terms: D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000235:genetics* / Q000503:physiopathology; D006961:Hyperparathyroidism / Q000097:blood / Q000503:physiopathology*; D007477:Ions; D008297:Male; D008875:Middle Aged; D010280:Parathyroid Glands / Q000187:drug effects / Q000503:physiopathology*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors / Q000097:blood; D012016:Reference Values
chemical_list: D007477:Ions; D010281:Parathyroid Hormone; D002118:Calcium